Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

36.27
Delayed Data
As of 3:59pm ET
 +0.04 / +0.11%
Today’s Change
26.16
Today|||52-Week Range
46.81
+17.68%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close36.23
Today’s open36.59
Day’s range35.92 - 36.96
Volume607,925
Average volume (3 months)386,234
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+34.47%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio71.1
Price/Sales10.05
Price/Book7.27

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+2.15+11.14%
ARRYArray Biopharma Inc+0.01+0.09%
LXRXLexicon Pharmaceutic...-0.04-0.36%
CBMCambrex Corp+0.70+1.35%
Data as of 4:02pm ET, 10/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts